Back to News
Market Impact: 0.1
REGN SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Regeneron Investors of Securities Class Action Lawsuit Deadline on September 14, 2026
Source: globenewswire.com
Legal & LitigationHealthcare & Biotech
Faruqi & Faruqi securities-litigation partner James Wilson is soliciting Regeneron investors who incurred losses to discuss potential legal options. The notice provides no details on alleged misconduct, damages, filing status, or financial impact on Regeneron.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.20
Ticker Sentiment
REGN-0.70
More News
- Apollo in talks to buy J&J orthopedics unit for nearly $20 billion
- Apollo Global in talks to acquire J&J’s orthopedics unit, Bloomberg News reports
- Flavio Bolsonaro faces corruption probe weeks before Brazil election
- Federal budget deficit reaches $2T in first 11 months of fiscal year 2026, CBO reports
- Super Micro Computer Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Super Micro Computer, Inc.
- Scholar Rock Announces FDA Approval of ISEMBYLD™ (apitegromab-mstn), the First and Only Muscle-Targeted Treatment for Children and Adults with Spinal Muscular Atrophy (SMA)